The FDA has announced updated labeling requirements for plant-based protein supplements, requiring manufacturers to disclose amino acid profiles and bioavailability scores on packaging. The new rules take effect in September 2026.

Industry leaders have expressed mixed reactions. Some welcome the transparency, arguing it will help consumers make more informed choices. Others warn that the compliance costs could push smaller brands out of the market.

Nutritionists say the change is long overdue, noting that many plant-based products have marketed misleading protein content without accounting for digestibility differences compared to animal-based sources.